Avalyn Pharma’s $175 Million Series C Financing Round

Wilson Sonsini Goodrich & Rosati advised Novo Holdings A/S and Vida Ventures on the transaction.Avalyn Pharma Inc. announced the closing of an oversubscribed $175 million Series…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here